Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Maximizing Safety in the Conduct of Alzheimer's Disease Fluid Biomarker Research in the Era of COVID-19

Schindler, Suzanne E. ; Jicha, Gregory A. ; Nelson, Peter T. ; Keene, C. Dirk ; Blennow, Kaj LU ; Molinuevo, José Luis ; Masters, Colin L. ; Hansson, Oskar LU orcid ; Teunissen, Charlotte E. and Galasko, Douglas , et al. (2020) In Journal of Alzheimer's disease : JAD 76(1). p.27-31
Abstract

The coronavirus disease 2019 (COVID-19) pandemic led to an abrupt halt of many Alzheimer's disease (AD) research studies at sites spanning the world. This is especially true for studies requiring in-person contact, such as studies collecting biofluids. Since COVID-19 is likely to remain a threat for an extended period, the resumption of fluid biomarker studies requires the development and implementation of procedures that minimize the risk of in-person visits to participants, staff, and individuals handling the biofluid samples. Some issues to consider include structuring the visit workflow to minimize contacts and promote social distancing; screening and/or testing participants and staff for COVID-19; wearing masks and performing hand... (More)

The coronavirus disease 2019 (COVID-19) pandemic led to an abrupt halt of many Alzheimer's disease (AD) research studies at sites spanning the world. This is especially true for studies requiring in-person contact, such as studies collecting biofluids. Since COVID-19 is likely to remain a threat for an extended period, the resumption of fluid biomarker studies requires the development and implementation of procedures that minimize the risk of in-person visits to participants, staff, and individuals handling the biofluid samples. Some issues to consider include structuring the visit workflow to minimize contacts and promote social distancing; screening and/or testing participants and staff for COVID-19; wearing masks and performing hand hygiene; and precautions for handling, storing, and analyzing biofluids. AD fluid biomarker research remains a vitally important public health priority and resuming studies requires appropriate safety procedures to protect research participants and staff.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Alzheimer’s disease, biofluids, biomarkers, COVID-19, safety
in
Journal of Alzheimer's disease : JAD
volume
76
issue
1
pages
5 pages
publisher
IOS Press
external identifiers
  • pmid:32568212
  • scopus:85087529539
ISSN
1387-2877
DOI
10.3233/JAD-200684
language
English
LU publication?
yes
id
be1a3a93-d365-414b-8067-92fcd7e514c1
date added to LUP
2020-07-20 11:38:48
date last changed
2024-04-03 10:41:45
@article{be1a3a93-d365-414b-8067-92fcd7e514c1,
  abstract     = {{<p>The coronavirus disease 2019 (COVID-19) pandemic led to an abrupt halt of many Alzheimer's disease (AD) research studies at sites spanning the world. This is especially true for studies requiring in-person contact, such as studies collecting biofluids. Since COVID-19 is likely to remain a threat for an extended period, the resumption of fluid biomarker studies requires the development and implementation of procedures that minimize the risk of in-person visits to participants, staff, and individuals handling the biofluid samples. Some issues to consider include structuring the visit workflow to minimize contacts and promote social distancing; screening and/or testing participants and staff for COVID-19; wearing masks and performing hand hygiene; and precautions for handling, storing, and analyzing biofluids. AD fluid biomarker research remains a vitally important public health priority and resuming studies requires appropriate safety procedures to protect research participants and staff.</p>}},
  author       = {{Schindler, Suzanne E. and Jicha, Gregory A. and Nelson, Peter T. and Keene, C. Dirk and Blennow, Kaj and Molinuevo, José Luis and Masters, Colin L. and Hansson, Oskar and Teunissen, Charlotte E. and Galasko, Douglas and Shaw, Leslie M. and Levey, Allan I. and Silverberg, Nina}},
  issn         = {{1387-2877}},
  keywords     = {{Alzheimer’s disease; biofluids; biomarkers; COVID-19; safety}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{27--31}},
  publisher    = {{IOS Press}},
  series       = {{Journal of Alzheimer's disease : JAD}},
  title        = {{Maximizing Safety in the Conduct of Alzheimer's Disease Fluid Biomarker Research in the Era of COVID-19}},
  url          = {{http://dx.doi.org/10.3233/JAD-200684}},
  doi          = {{10.3233/JAD-200684}},
  volume       = {{76}},
  year         = {{2020}},
}